752 related articles for article (PubMed ID: 30244634)
21. Expression profile and clinical significance of microRNAs in papillary thyroid carcinoma.
Peng Y; Li C; Luo DC; Ding JW; Zhang W; Pan G
Molecules; 2014 Aug; 19(8):11586-99. PubMed ID: 25100252
[TBL] [Abstract][Full Text] [Related]
22. Exosomal circular RNA hsa_circ_007293 promotes proliferation, migration, invasion, and epithelial-mesenchymal transition of papillary thyroid carcinoma cells through regulation of the microRNA-653-5p/paired box 6 axis.
Lin Q; Qi Q; Hou S; Chen Z; Jiang N; Zhang L; Lin C
Bioengineered; 2021 Dec; 12(2):10136-10149. PubMed ID: 34866540
[TBL] [Abstract][Full Text] [Related]
23. Aberrant expression of five miRNAs in papillary thyroid carcinomas.
Qiao DH; He XM; Deng X; Ji YC; Yang H; Cheng L; Zhou XY
J Clin Lab Anal; 2021 Sep; 35(9):e23907. PubMed ID: 34268792
[TBL] [Abstract][Full Text] [Related]
24. New global analysis of the microRNA transcriptome of primary tumors and lymph node metastases of papillary thyroid cancer.
Saiselet M; Gacquer D; Spinette A; Craciun L; Decaussin-Petrucci M; Andry G; Detours V; Maenhaut C
BMC Genomics; 2015 Oct; 16():828. PubMed ID: 26487287
[TBL] [Abstract][Full Text] [Related]
25. Transcription factor SP1-induced microRNA-146b-3p facilitates the progression and metastasis of colorectal cancer via regulating FAM107A.
Wang D; Feng M; Ma X; Tao K; Wang G
Life Sci; 2021 Jul; 277():119398. PubMed ID: 33831429
[TBL] [Abstract][Full Text] [Related]
26. CircRNA NRIP1 promotes papillary thyroid carcinoma progression by sponging mir-195-5p and modulating the P38 MAPK and JAK/STAT pathways.
Li C; Zhu L; Fu L; Han M; Li Y; Meng Z; Qiu X
Diagn Pathol; 2021 Oct; 16(1):93. PubMed ID: 34689819
[TBL] [Abstract][Full Text] [Related]
27. MiR-202-3p functions as a tumor suppressor and reduces cell migration and invasion in papillary thyroid carcinoma.
Chen J; Yin J; Liu J; Zhu RX; Zheng Y; Wang XL
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1145-1150. PubMed ID: 30779083
[TBL] [Abstract][Full Text] [Related]
28. Long Noncoding RNA HOXA-AS2 Promotes Papillary Thyroid Cancer Progression by Regulating miR-520c-3p/S100A4 Pathway.
Xia F; Chen Y; Jiang B; Du X; Peng Y; Wang W; Huang W; Feng T; Li X
Cell Physiol Biochem; 2018; 50(5):1659-1672. PubMed ID: 30384358
[TBL] [Abstract][Full Text] [Related]
29. KPNA4 regulated by miR-548b-3p promotes the malignant phenotypes of papillary thyroid cancer.
Feng L; Wang R; Yang Y; Shen X; Shi Q; Lian M; Ma H; Fang J
Life Sci; 2021 Jan; 265():118743. PubMed ID: 33188837
[TBL] [Abstract][Full Text] [Related]
30. Plasma Exosomal miR-146b-5p and miR-222-3p are Potential Biomarkers for Lymph Node Metastasis in Papillary Thyroid Carcinomas.
Jiang K; Li G; Chen W; Song L; Wei T; Li Z; Gong R; Lei J; Shi H; Zhu J
Onco Targets Ther; 2020; 13():1311-1319. PubMed ID: 32103998
[TBL] [Abstract][Full Text] [Related]
31. miR-199a-5p inhibits the progression of papillary thyroid carcinoma by targeting SNAI1.
Ma S; Jia W; Ni S
Biochem Biophys Res Commun; 2018 Feb; 497(1):181-186. PubMed ID: 29427661
[TBL] [Abstract][Full Text] [Related]
32. In Situ Hybridization Analysis of miR-146b-5p and miR-21 in Thyroid Nodules: Diagnostic Implications.
Guo Z; Hardin H; Montemayor-Garcia C; Asioli S; Righi A; Maletta F; Sapino A; Lloyd RV
Endocr Pathol; 2015 May; 26(2):157-63. PubMed ID: 25771986
[TBL] [Abstract][Full Text] [Related]
33. Circular RNA circBACH2 plays a role in papillary thyroid carcinoma by sponging miR-139-5p and regulating LMO4 expression.
Cai X; Zhao Z; Dong J; Lv Q; Yun B; Liu J; Shen Y; Kang J; Li J
Cell Death Dis; 2019 Feb; 10(3):184. PubMed ID: 30796202
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-520a-3p suppresses epithelial-mesenchymal transition, invasion, and migration of papillary thyroid carcinoma cells via the JAK1-mediated JAK/STAT signaling pathway.
Bi CL; Zhang YQ; Li B; Guo M; Fu YL
J Cell Physiol; 2019 Apr; 234(4):4054-4067. PubMed ID: 30206929
[TBL] [Abstract][Full Text] [Related]
35. MiR-548c-3p suppressed the progression of papillary thyroid carcinoma via inhibition of the HIF1α-mediated VEGF signaling pathway.
Du Y; Zhu J; Chu BF; Yang YP; Zhang SL
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6570-6578. PubMed ID: 31378898
[TBL] [Abstract][Full Text] [Related]
36. Clinical Impact of Androgen Receptor-Suppressing miR-146b Expression in Papillary Thyroid Cancer Aggressiveness.
Chou CK; Chi SY; Hung YY; Yang YC; Fu HC; Wang JH; Chen CC; Kang HY
J Clin Endocrinol Metab; 2023 Oct; 108(11):2852-2861. PubMed ID: 37220080
[TBL] [Abstract][Full Text] [Related]
37. MiR-296-5p suppresses papillary thyroid carcinoma cell growth via targeting PLK1.
Zhou SL; Tang QL; Zhou SX; Ren RZ
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2084-2091. PubMed ID: 30915753
[TBL] [Abstract][Full Text] [Related]
38. MiR-758-3p regulates papillary thyroid cancer cell proliferation and migration by targeting TAB1.
Chen J; Xu Z; Yu C; Wu Z; Yin Z; Fang F; Chen B
Pharmazie; 2019 Apr; 74(4):235-238. PubMed ID: 30940308
[TBL] [Abstract][Full Text] [Related]
39. A novel lncRNA n384546 promotes thyroid papillary cancer progression and metastasis by acting as a competing endogenous RNA of miR-145-5p to regulate AKT3.
Feng J; Zhou Q; Yi H; Ma S; Li D; Xu Y; Wang J; Yin S
Cell Death Dis; 2019 Jun; 10(6):433. PubMed ID: 31160577
[TBL] [Abstract][Full Text] [Related]
40. LncRNA-HCG18 regulates the viability, apoptosis, migration, invasion and epithelial-mesenchymal transition of papillary thyroid cancer cells via regulating the miR-106a-5p/PPP2R2A axis.
Zhu Y; Zhao J; Tan L; Lin S; Long M; Peng X
Pathol Res Pract; 2021 May; 221():153395. PubMed ID: 33798913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
